InsideArbitrage Event Driven Monitor – May 19, 2025
Merger Arbitrage
- INZY: The acquisition of Inozyme Pharma, Inc. (INZY) by BioMarin Pharmaceutical Inc. (BMRN), for a closing value of $270 million. Under the terms of the agreement, BioMarin will commence a cash tender offer to acquire all of the outstanding shares of Inozyme common stock at a price of $4.00 per share, representing a premium of 181.69% from the stock’s last close. (Press Release)
- BRFS: The acquisition of BRF S.A. (BRFS) by Marfrig Global Foods S.A. (MRRTY), for a closing value of $8.11 billion. Under the terms of the agreement, BRF shareholders will receive 0.8521 Marfrig shares for each BRF share they own on the closing date, at a price of about $3.66 per ADS, representing a 1.39% premium from the stock’s last close. (Press Release)
- LBRDA: Liberty Broadband (LBRDA) announced it has agreed to accelerate the closing of its acquisition by Charter (CHTR) to occur along with Charter’s combination with Cox. If Charter and Cox don’t complete their deal, Liberty Broadband can choose to speed up the closing of its deal with Charter.
You can check out new deals, all deal updates, and spreads on active deals in our Merger Arbitrage Tool for premium members here.
Only plus or premium subscribers can access this post. Subscribe today.
